Kenyan long-distance running star Peres Jepchirchir has been handed a three-year ban from athletics after testing positive for the prohibited blood-boosting substance erythropoietin (EPO). The suspension marks a major setback for one of Kenya’s most celebrated female athletes, whose impressive career includes Olympic gold, world championship glory and victories at several prestigious international marathons. The Athletics Integrity Unit (AIU), which oversees anti-doping matters in track and field, announced the sanction on Thursday, November 19, 2026. Jepchirchir admitted breaching anti-doping regulations and accepted the consequences, including the disqualification of her competitive results dating back to July 17, 2026. The decision also means she will lose her 2026 Sydney Marathon victory, a result that had added another major achievement to her decorated career.
The doping case emerged after an out-of-competition sample collected from Jepchirchir in Kenya before her participation in the Sydney Marathon returned an adverse analytical finding for EPO. According to the Athletics Integrity Unit, the sample produced the adverse finding on September 17, 2026. The Kenyan runner had initially denied using the prohibited substance when questioned by anti-doping investigators. She reportedly said she did not know how the positive finding had occurred. However, she later signed an admission of anti-doping rule violations and acceptance of consequences, agreeing to the sanctions imposed by the authorities.
The three-year suspension follows a provisional ban that was imposed in October after the adverse analytical finding became known. The final decision covers violations involving the presence of a prohibited substance or its markers in an athlete’s sample and the use or attempted use of a prohibited substance or method. By accepting the consequences, Jepchirchir also agreed to the disqualification of all her competitive results from July 17, 2026. This includes her impressive victory at the Sydney Marathon, which took place on August 30, 2026. The decision has therefore affected both her immediate career prospects and the official record of her recent performances.
EPO, also known as erythropoietin, is a hormone naturally produced mainly by the kidneys that stimulates the production of red blood cells. The substance is prohibited in competitive sports because synthetic EPO can increase the number of red blood cells responsible for carrying oxygen around the body. Greater oxygen delivery can improve an athlete’s endurance and ability to sustain intense physical activity over long distances. This makes EPO particularly attractive to athletes competing in endurance events such as marathon running and long-distance cycling. However, its misuse carries serious health risks, including increased blood viscosity, blood clots, stroke and heart complications.
Jepchirchir’s suspension is particularly significant because she has spent years establishing herself among the leading female marathon runners in the world. The 33-year-old athlete won the women’s marathon gold medal at the 2021 Tokyo Olympic Games, bringing international recognition to her already impressive running career. She also secured major marathon victories in New York in 2021, Boston in 2022 and London in 2024. Her success at the 2025 World Athletics Championships in Tokyo further strengthened her reputation as one of the leading figures in women’s distance running. Before the doping case, she had also established herself as a former world record holder in the half marathon.
One of the most recent highlights of her career was her victory at the 2026 Sydney Marathon in Australia. Jepchirchir delivered a commanding performance on August 30, crossing the finish line in 2:18:31. She finished more than three minutes ahead of compatriot Irine Cheptai, who had taken second place. The victory appeared to add another prestigious international title to her collection and demonstrated her competitive strength over the marathon distance. However, the subsequent doping investigation has resulted in the disqualification of that performance.
Following the disqualification, Sydney Marathon organisers announced that Irine Cheptai would be elevated to the 2026 women’s champion. Cheptai’s promotion means she will receive official recognition for finishing first among the eligible athletes after Jepchirchir’s results were removed. The development represents a significant change to the race’s final standings and gives Cheptai an opportunity to claim a major international marathon title. It also highlights the wider consequences of anti-doping violations, which can affect other athletes who competed fairly in the same event. For Jepchirchir, losing the Sydney title adds another difficult consequence to an already damaging disciplinary decision.
The case has also renewed attention on Kenya’s ongoing struggle with doping violations in international athletics. Kenya has produced some of the world’s greatest marathon runners, with its athletes regularly dominating major road races and international championships. However, repeated doping cases involving Kenyan competitors have raised questions about the systems used to protect clean sport. The Athletics Integrity Unit has sanctioned more than 140 Kenyan athletes since its establishment in 2017. Although authorities have acknowledged progress in the country’s anti-doping efforts, the latest cases demonstrate that significant challenges remain.
Jepchirchir is not the only prominent Kenyan athlete to face disciplinary action in the latest announcements. Distance runner Veronica Loleo, who won silver in the half marathon at the 2026 World Road Running Championships, also received a three-year ban after testing positive for EPO. Meanwhile, marathon runner Ronald Korir was handed a six-year suspension following unexplained abnormalities in his Athlete Biological Passport. The biological passport programme monitors changes in an athlete’s blood over time to identify possible signs of prohibited methods or substances. These additional sanctions have intensified discussions about doping prevention, athlete education and the need for stronger enforcement within Kenyan athletics.
Athletics Integrity Unit chief executive Brett Clothier acknowledged that Kenya had made progress in addressing doping but maintained that more work was necessary. He also highlighted the need to strengthen the country’s anti-doping institutions and address criminal networks that facilitate the use of prohibited substances. Such networks can expose athletes to dangerous drugs while undermining the credibility of competitive sport. The issue is particularly important for Kenya because athletics remains a major source of national pride and international recognition. Maintaining confidence in Kenyan athletes requires effective testing, education and accountability across all levels of competition.
The three-year ban presents a major interruption to Jepchirchir’s career, especially given her achievements over the past several years. At 33, she had remained a prominent competitor in international marathon racing and was expected to continue participating in major events. The suspension means she will be unable to compete in sanctioned athletics competitions during the period covered by the ban. Her disqualified results also affect her official record and remove the Sydney Marathon victory from her achievements. The case serves as a reminder that even athletes with established reputations and impressive championship records remain subject to anti-doping regulations.
Peres Jepchirchir’s three-year doping ban has therefore become one of the most significant developments in Kenyan athletics in 2026. Her positive EPO finding, subsequent admission of anti-doping rule violations and acceptance of the disqualification of her recent results have brought an abrupt setback to a career built on major international victories. The loss of her Sydney Marathon title and the promotion of Irine Cheptai further demonstrate the consequences of the ruling. The case also adds to the pressure on Kenyan athletics authorities to strengthen their fight against performance-enhancing substances. For a country celebrated around the world for producing exceptional distance runners, protecting the integrity of the sport remains essential to preserving its reputation and future success.

